CV Sciences, Inc.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of James A Mcnulty. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate James A Mcnulty has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:INTI / Inhibitor Therapeutics, Inc. Chief Financial Officer 1,946,135
US:CVSI / CV Sciences, Inc. Director 230,000
US:BDSI / Biodelivery Sciences International SVP Finance and Treasurer 49,399
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by James A Mcnulty. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CVSI / CV Sciences, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CVSI / CV Sciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CVSI / CV Sciences, Inc. Insider Trades
Insider Sales CVSI / CV Sciences, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CVSI / CV Sciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CVSI / CV Sciences, Inc. Insider Trades
Insider Purchases INTI / Inhibitor Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CVSI / CV Sciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INTI / Inhibitor Therapeutics, Inc. Insider Trades
Insider Sales INTI / Inhibitor Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CVSI / CV Sciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INTI / Inhibitor Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by James A Mcnulty as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-02-19 2024-12-02 5 INTI Inhibitor Therapeutics, Inc.
Common Stock
G - Gift 1,000,000 1,946,135 105.69
2023-05-17 3 INTI Inhibitor Therapeutics, Inc.
Common Stock
20,101,057
2023-05-17 2023-05-05 4 INTI Inhibitor Therapeutics, Inc.
Common Stock
J - Other 20,101,057 26,101,057 335.02
2023-05-17 2023-05-05 4 INTI Inhibitor Therapeutics, Inc.
Common Stock
J - Other 398,135 946,135 72.65
2023-05-17 2023-05-05 4 INTI Inhibitor Therapeutics, Inc.
Common Stock
J - Other -79,627,069 0 -100.00
2022-12-22 3 INTI Inhibitor Therapeutics, Inc.
Common Stock
548,000
2022-12-22 3 INTI Inhibitor Therapeutics, Inc.
Common Stock
85,627,069
2020-06-18 2020-06-16 4 CVSI CV Sciences, Inc.
Common Stock
A - Award 230,000 230,000
2018-06-06 2018-02-05 4 CANV CV Sciences, Inc.
Stock Option (right to buy)
A - Award 40,000 40,000
2017-05-26 2017-03-17 4 CVSI CV Sciences, Inc.
Common Stock
J - Other 1,450,500 1,545,500 1,526.84 0.41 599,056 638,292
2017-05-26 2016-10-05 4 CVSI CV Sciences, Inc.
Common Stock
J - Other 45,000 95,000 90.00 0.40 18,225 38,475
2016-07-21 2016-07-06 4 CVSI CV Sciences, Inc.
Stock Option (right to buy)
A - Award 200,000 250,000 400.00
2016-07-21 2016-07-06 4 CVSI CV Sciences, Inc.
Stock Option (right to buy)
A - Award 50,000 50,000
2016-04-08 3 CVSS CV Sciences, Inc.
Common Stock
100,000
2016-04-08 3 CVSS CV Sciences, Inc.
Common Stock
100,000
2014-02-14 2013-05-29 5 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
A - Award 1,240 49,399 2.57 3.92 4,861 193,644
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -10,977 0 -100.00
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -10,812 0 -100.00
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -24,844 0 -100.00
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -27,080 0 -100.00
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -12,275 0 -100.00
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -3,235 0 -100.00
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -89,223 49,399 -64.36 8.73 -778,917 431,253
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 10,977 138,622 8.60 1.78 19,539 246,747
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 10,812 127,645 9.25 3.55 38,383 453,140
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 24,844 116,833 27.01 2.43 60,371 283,904
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 27,080 91,989 41.72 3.90 105,612 358,757
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 12,275 64,909 23.32 3.05 37,439 197,972
2014-01-28 2014-01-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 3,235 52,634 6.55 3.40 10,999 178,956
2013-08-19 2013-08-14 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
P - Purchase 5,000 49,399 11.26 4.50 22,500 222,296
2012-09-27 2012-09-26 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -18,616 0 -100.00
2012-09-27 2012-09-26 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -18,616 43,159 -30.14 6.14 -114,302 264,996
2012-09-27 2012-09-26 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 18,616 61,775 43.13 3.83 71,299 236,598
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -6,092 0 -100.00
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -10,000 0 -100.00
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -26,189 0 -100.00
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -32,408 0 -100.00
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -34,109 0 -100.00
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -6,092 43,159 -12.37 5.00 -30,460 215,795
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -10,000 49,251 -16.88 5.00 -50,000 246,255
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -26,189 59,251 -30.65 5.00 -130,945 296,255
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -32,408 85,440 -27.50 5.00 -162,040 427,200
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -34,109 117,848 -22.45 5.00 -170,545 589,240
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 6,092 151,957 4.18 2.01 12,245 305,434
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 10,000 145,865 7.36 3.03 30,300 441,971
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 26,189 135,865 23.88 2.94 76,996 399,443
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 32,408 109,676 41.94 2.85 92,363 312,577
2012-07-10 2012-07-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 34,109 77,268 79.03 2.42 82,544 186,989
2012-07-05 2012-07-03 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -12,479 0 -100.00
2012-07-05 2012-07-03 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -12,479 426,105 -2.85 4.62 -57,653 1,968,605
2012-07-05 2012-07-03 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 12,479 451,353 2.84 1.96 24,459 884,652
2012-07-05 2012-07-02 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -3,769 0 -100.00
2012-07-05 2012-07-02 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -6,667 0 -100.00
2012-07-05 2012-07-02 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -6,667 438,584 -1.50 4.50 -30,002 1,973,628
2012-07-05 2012-07-02 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -3,769 445,261 -0.84 4.50 -16,960 2,003,674
2012-07-05 2012-07-02 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 3,769 438,874 0.87 2.01 7,576 882,137
2012-07-05 2012-07-02 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 6,667 435,105 1.56 1.96 13,067 852,806
2012-07-05 2012-06-28 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -2,323 0 -100.00
2012-07-05 2012-06-28 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -2,323 449,030 -0.51 4.50 -10,454 2,020,635
2012-07-05 2012-06-28 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 2,323 428,248 0.55 2.01 4,669 860,778
2012-05-10 2012-05-08 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -15,603 0 -100.00
2012-05-10 2012-05-08 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Options
M - Exercise -6,093 6,092 -50.00
2012-05-10 2012-05-08 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale X -21,696 43,159 -33.45 4.00 -86,784 172,636
2012-05-10 2012-05-08 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 15,603 64,855 31.68 2.05 31,986 132,953
2012-05-10 2012-05-08 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 6,093 49,252 14.12 2.01 12,247 98,997
2012-03-13 2012-02-15 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option
A - Award 19,156 19,156
2012-03-13 2012-02-09 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Option
A - Award 51,020 51,020
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)